We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cannabis Reduces Headache and Migraine Severity by Half

By HospiMedica International staff writers
Posted on 02 Dec 2019
Inhaled cannabis significantly reduces self-reported headache and migraine severity, according to a new study.

Researchers at Washington State University (WSU; Spokane, WA, USA) conducted a study that analyzed archival data from Strainprint, a smartphone app that allows patients to track their symptoms before and after consumption of medical cannabis purchased from Canadian producers and distributors. More...
The data analyzed was submitted by more than 1,300 patients, who used the app in 12,293 sessions to track changes in headache severity before and after cannabis use, and another 653 who used the app over 7,441 sessions to track changes in migraine severity.

The results showed a 47.3% reduction in headache severity and a 49.6% reduction in migraine ratings following cannabis use. Men reported larger headache reductions than women, and use of concentrates (such as cannabis oil), produced a larger reduction in headache severity ratings than cannabis flower. No significant difference in pain reduction was seen among strains that were higher or lower in levels of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), suggesting that other cannabinoids (or even terpenes), may promote headache and migraine relief. The study was published on November 9, 2019, in The Journal of Pain.

“I suspect there are some slight overestimates of effectiveness. My hope is that this research will motivate researchers to take on the difficult work of conducting placebo-controlled trials,” said lead author Carrie Cuttler, PhD, of the WSU Translational Addiction Research Center. “In the meantime, this at least gives medical cannabis patients and their doctors a little more information about what they might expect from using cannabis to manage these conditions.”

Cannabis, also known as Marijuana, is composed of dried buds and leaves of varieties of the Cannabis sativa plant. The two most active components in marijuana are THC and CBD, but there are over 100 cannabinoids in the plants themselves. THC seems to cause the euphoria reported by users, and helps relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high.

Related Links:
Washington State University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.